`Alzheimer`s drug to be developed within five years`
Washington: Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.
Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.
In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.
Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.
Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.
More from India
More from World
More from Sports
More from Entertaiment
- Watch: How Russian special forces Spetsnaz will end terror of ISIS
- Panel discussion on BJP MLAs assaulting legislator Rashid inside J&K Assembly
- Two J&K MLAs clash over beef party issue in Legislative Assembly
- Vladimir Putin's attack on ISIS making America and NATO nations uneasy?
- PM Modi breaks silence on Dadri lynching incident
- Latest condition of Navjot Singh Sidhu: Sherry Paaji making steady recovery!
- FIR against Asaduddin Owaisi for posting objectionable picture of Yogi Adityanath on Facebook
- Bihar has to choose between 'jungle raj' and 'vikas Raj': Narendra Modi
- Shocking! Saudi employer chops off Indian maid's hands
- Salman Khan's songs: Best five!